Research

Research

My research develops and applies causal inference and machine learning methods for evaluating health policies and treatments, with a focus on how effects vary across people. This page describes the five main strands of that work, the projects that supported it, and the people I have worked with.

01

Causal inference for comparative effectiveness and economic evaluation

Δ effectΔ costthreshold

Economic evaluations often rely on observational data, in which treated and untreated patients differ in ways that affect outcomes. An early strand of my work compared estimators for this setting. Using simulations and applied case studies, we found that semiparametric methods such as targeted maximum likelihood estimation and bias-corrected matching performed better than standard propensity score approaches, in terms of bias and efficiency, when the models were misspecified.

Later work extended these methods to longitudinal settings with time-varying confounding, including the evaluation of dynamic treatment regimes in critical care, and to electronic health record data in which biomarkers are measured only when clinicians decide to measure them. The common aim has been to make adaptive treatment strategies evaluable with the data that health systems routinely collect.

Key papers

02

Causal machine learning and policy learning

treat →individual treatment effect →

A policy with a small average effect may help some groups and not others. This strand applies causal machine learning methods, including causal forests, meta-learners and policy learning, to estimate heterogeneous treatment effects and to learn targeting rules in health policy and clinical settings. Applications include Indonesia's national health insurance program and the question of how individualized treatment effect estimates can be used within cost-effectiveness decision models.

On the methods side, an MRC New Investigator Research Grant with James Cussens supported work on policy learning with rare outcomes, algorithms for learning optimal policy trees, and machine learning for staggered difference-in-differences designs. I was a member of the ISPOR task force that produced the PALISADE checklist for machine learning in health economics and outcomes research, and co-led a review of methods for estimating individualized treatment effects for use in health technology assessment.

Key papers

03

Quasi-experimental evaluation of health policies

policysynthetictreatedtime

When a payment reform or an incentive scheme is introduced across a whole health system, the counterfactual has to be constructed from comparison units. Using data from the English NHS, we examined how the synthetic control method behaves when there are multiple treated units, and compared it with difference-in-differences and related designs, to show how conclusions can depend on the choice of method.

We have used these designs to evaluate hospital payment reforms and provider incentive programs in England. More recent work, with colleagues at Imperial College London, evaluates digital-first models of primary care and the trade-off between equity and efficiency in access.

Key papers

04

Health systems in low- and middle-income countries

averagebaseline quality →effect

This strand applies causal methods to questions of health system performance in low- and middle-income countries, including quality improvement policies, health expenditure expansions and provider payment reforms. In South Africa, we examined whether national facility quality standards improved care uniformly, or only for clinics already above a baseline level of quality, which has implications for how quality incentives are designed and targeted.

In Indonesia, we estimated the productivity of the health system, and these estimates have been used in supply-side cost-effectiveness threshold estimates for reimbursement decisions. Related work covers maternal health care in Malawi. Much of this research was carried out under the NIHR-funded GHE2 program at the University of York and the NIHR Global Health Research Unit on health financing for universal health coverage.

Key papers

05

Conflict, violence, mental health and economic outcomes

eventbeforeafter

Conflict, violence and mental ill-health do not occur at random, which makes their consequences hard to measure. This strand applies causal inference methods to these questions. With Rodrigo Moreno-Serra and colleagues at York, we studied the effects of armed conflict in Colombia on child health and on the financing of the health system.

In the United States, we estimated the effect of psychological distress in adolescence on health and economic outcomes in adulthood. In Brazil, the BRAVE project examined the relationship between pandemic distancing policies and violence against women. My current MQ Foundation Fellowship in Economics and Mental Health Research continues this work on the economics of mental health.

Key papers

Funding

Funded projects

Grants held as principal investigator or co-investigator, most recent first.

Principal investigator

MQ Foundation Fellowship in Economics and Mental Health Research

Kennedy Forum · 2026–2027

Principal investigator

A generative machine-learning model to simulate trajectories of patients with chronic lymphocytic leukemia

Clever Access S.A. (service agreement) · 2026–2027

Co-investigator

Developing a rapid AI-based policy probing and observational research tool

Wellcome Data Prize · 2022–2023

Co-investigator

BRAVE: COVID-19, social distancing and violence against women in Brazil

MRC / UKRI GCRF–Newton Fund · 2020–2022

Co-investigator

HTx: Next Generation Health Technology Assessment

European Commission · 2019–2023

Co-investigator

GHE2: the Economics and Econometrics of Global Health Systems, Programs and Policies

NIHR Global Health Research · 2017–2020

Principal investigator

Improving statistical methods to address confounding in the economic evaluation of health interventions

MRC Early Career Fellowship in the Economics of Health · 2014–2017

Software

Software

fastpolicytree (R package, CRAN). Constructs optimal policy trees from covariate data and doubly robust reward estimates. It is faster than the policytree package, particularly for discrete covariates. James Cussens developed it within the MRC-funded Tailoring project, which I led; the methods are described in Cussens, Hatamyar, Shah and Kreif (2025). Install with install.packages("fastpolicytree").

People

Collaborators and visiting positions

I was a visiting graduate student at the University of California, Berkeley, in 2010, a visiting researcher in its Division of Biostatistics in 2015, and a visiting researcher at its Center for Targeted Machine Learning and Causal Inference in 2022. In 2016 I was a visiting researcher at the Kaiser Permanente Division of Research.

I work with economists, biostatisticians, epidemiologists and clinicians at the University of Washington, the University of York, the London School of Hygiene and Tropical Medicine, Imperial College London and Harvard, and with partners in Indonesia, Colombia, Brazil, South Africa and Malawi.

Students

Students and postdocs

Current and former PhD students I supervise or advise as a committee member, and postdocs I have supervised, with links to their profiles where available.

Current

  • 2026–

    Zilin ChengPhD, The CHOICE Institute, University of Washington (committee member). Dissertation on genomic risk information in colorectal cancer screening: polygenic risk thresholds and screening response to monogenic risk disclosure.

  • 2024–

    Emily CallenPhD, The CHOICE Institute, University of Washington (committee member). Dissertation on the effectiveness of state HIV pre-exposure prophylaxis drug assistance programs.

  • 2021–

    Nadine Kraamwinkel-JhaPhD, University of Gothenburg (co-supervisor). Dissertation on heterogeneity in the effects of public health and development policies in low- and middle-income countries.

Former

  • 2024–2026

    Ben NwoguPhD, The CHOICE Institute, University of Washington (committee member). Thesis on the real-world comparative effectiveness and cost-effectiveness of therapies for advanced prostate cancer.

  • 2020–2023

    Julia HatamyarPostdoctoral research fellow on the MRC New Investigator Research Grant, University of York. Co-author on policy learning with rare outcomes, optimal policy trees and machine learning for staggered difference-in-differences.

  • 2019–2023

    Vishalie ShahPhD, University of York. Thesis on evaluating the heterogeneous impacts of Indonesia's national health insurance scheme using causal machine learning.

  • 2019–2023

    Daniela RodriguesPhD, Imperial College London. Thesis on the evaluation of digital-first models of primary care using routinely collected data.

  • 2018–2022

    Finn McGuirePhD, University of York. Thesis on methods to evaluate health policies in low- and middle-income countries, with applications in Malawi and South Africa.

  • 2018

    Silvia Moler-ZapataMSc in Health Economics, University of York. Dissertation on the health effects of expansions in health expenditure in Indonesia, later published in Applied Health Economics and Health Policy.